Filing Details
- Accession Number:
- 0001546927-16-000462
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2016-03-14 15:33:55
- Reporting Period:
- 2016-03-11
- Filing Date:
- 2016-03-14
- Accepted Time:
- 2016-03-14 15:33:55
- Original Submission Date:
- 2016-03-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1360214 | Imprimis Pharmaceuticals Inc. | IMMY | Pharmaceutical Preparations (2834) | 450567010 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1595855 | Opaleye Management Inc. | 175 Federal Street, 6Th Floor Boston MA 02110 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-03-11 | 45,000 | $3.60 | 1,250,000 | No | 4 | P | Indirect | See Foonote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Foonote |
Footnotes
- Securities reported herein for Opaleye Management, Inc. (the "Company) represent Common Stock beneficially owned and held of record by the Company and Opaleye, L.P., a private fund for which the Company serves as the investment manager (the "Fund"). James Silverman is the President and sole shareholder of the Company. The Company, the Fund and Mr. Silverman (the "Reporting Persons") are each beneficial owners and have an address of 175 Federal Street, 6th Floor, Boston, MA 02110. The Reporting Persons disclaim beneficial ownership, within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of such portion of the shares and warrants in which the Reporting Persons have no actual pecuniary interest therein.
Billionaire Hedge Funds
